APO Research

APO RESEARCH · REPORT

Probiotic Pills

Selected research

Market Outlook & Growth Opportunities

Global Probiotic Pills Market Outlook and Growth Opportunities 2026

Market perspective

The global Probiotic Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Probiotic Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Probiotic Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Probiotic Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Probiotic Pills market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Probiotic Pills market include Votary, Smidge, OHKISEIYAKU, Nutrition Care Pharmaceuticals, L.P Gentle Herbal, Eishin Pharmaceutical Co., Ltd., DSM and CVS Caremark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Probiotic Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Probiotic Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Probiotic Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Probiotic Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Probiotic Pills Segment by Company

Votary

Smidge

OHKISEIYAKU

Nutrition Care Pharmaceuticals

L.P Gentle Herbal

Eishin Pharmaceutical Co., Ltd.

DSM

CVS Caremark

Probiotic Pills Segment by Type

Capsule

Medicinal Tablet

Other

Probiotic Pills Segment by Application

E-commerce

Drugstore

Clinic

Probiotic Pills Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Probiotic Pills status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Probiotic Pills market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Probiotic Pills significant trends, drivers, influence factors in global and regions.

6. To analyze Probiotic Pills competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotic Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotic Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotic Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Probiotic Pills market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Probiotic Pills industry.

Chapter 3: Detailed analysis of Probiotic Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Probiotic Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Probiotic Pills in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Probiotic Pills Industry Trends Table 2. Probiotic Pills Industry Drivers Table 3. Probiotic Pills Industry Opportunities and Challenges Table 4. Probiotic Pills Industry Restraints Table 5. Global Probiotic Pills Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Probiotic Pills Revenue Share by Company (2021-2026) Table 7. Global Probiotic Pills Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Probiotic Pills Sales Volume Share by Company (2021-2026) Table 9. Global Probiotic Pills Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Probiotic Pills Company Ranking, (2024-2026) & (USD Million) Table 11. Global Probiotic Pills Key Company Manufacturing Base & Headquarters Table 12. Global Probiotic Pills Company, Product Type & Application Table 13. Global Probiotic Pills Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Probiotic Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsule Table 18. Significant Companies of Medicinal Tablet Table 19. Significant Companies of Other Table 20. Global Probiotic Pills Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Probiotic Pills Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Probiotic Pills Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Probiotic Pills Sales Volume Share by Type (2021-2026) Table 24. Global Probiotic Pills Sales Volume Share by Type (2027-2032) Table 25. Global Probiotic Pills Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Probiotic Pills Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Probiotic Pills Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Probiotic Pills Sales Value Share by Type (2021-2026) Table 29. Global Probiotic Pills Sales Value Share by Type (2027-2032) Table 30. Significant Companies of E-commerce Table 31. Significant Companies of Drugstore Table 32. Significant Companies of Clinic Table 33. Global Probiotic Pills Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Probiotic Pills Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Probiotic Pills Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Probiotic Pills Sales Volume Share by Application (2021-2026) Table 37. Global Probiotic Pills Sales Volume Share by Application (2027-2032) Table 38. Global Probiotic Pills Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Probiotic Pills Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Probiotic Pills Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Probiotic Pills Sales Value Share by Application (2021-2026) Table 42. Global Probiotic Pills Sales Value Share by Application (2027-2032) Table 43. Global Probiotic Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Probiotic Pills Sales by Region (2021-2026) & (K Units) Table 45. Global Probiotic Pills Sales Market Share by Region (2021-2026) Table 46. Global Probiotic Pills Sales by Region (2027-2032) & (K Units) Table 47. Global Probiotic Pills Sales Market Share by Region (2027-2032) Table 48. Global Probiotic Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Probiotic Pills Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Probiotic Pills Sales Value Share by Region (2021-2026) Table 51. Global Probiotic Pills Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Probiotic Pills Sales Value Share by Region (2027-2032) Table 53. Global Probiotic Pills Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Probiotic Pills Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Probiotic Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Probiotic Pills Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Probiotic Pills Sales by Country (2021-2026) & (K Units) Table 58. Global Probiotic Pills Sales Market Share by Country (2021-2026) Table 59. Global Probiotic Pills Sales by Country (2027-2032) & (K Units) Table 60. Global Probiotic Pills Sales Market Share by Country (2027-2032) Table 61. Global Probiotic Pills Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Probiotic Pills Sales Value Market Share by Country (2021-2026) Table 63. Global Probiotic Pills Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Probiotic Pills Sales Value Market Share by Country (2027-2032) Table 65. Votary Company Information Table 66. Votary Business Overview Table 67. Votary Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Votary Probiotic Pills Product Portfolio Table 69. Votary Recent Development Table 70. Smidge Company Information Table 71. Smidge Business Overview Table 72. Smidge Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Smidge Probiotic Pills Product Portfolio Table 74. Smidge Recent Development Table 75. OHKISEIYAKU Company Information Table 76. OHKISEIYAKU Business Overview Table 77. OHKISEIYAKU Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. OHKISEIYAKU Probiotic Pills Product Portfolio Table 79. OHKISEIYAKU Recent Development Table 80. Nutrition Care Pharmaceuticals Company Information Table 81. Nutrition Care Pharmaceuticals Business Overview Table 82. Nutrition Care Pharmaceuticals Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Nutrition Care Pharmaceuticals Probiotic Pills Product Portfolio Table 84. Nutrition Care Pharmaceuticals Recent Development Table 85. L.P Gentle Herbal Company Information Table 86. L.P Gentle Herbal Business Overview Table 87. L.P Gentle Herbal Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. L.P Gentle Herbal Probiotic Pills Product Portfolio Table 89. L.P Gentle Herbal Recent Development Table 90. Eishin Pharmaceutical Co., Ltd. Company Information Table 91. Eishin Pharmaceutical Co., Ltd. Business Overview Table 92. Eishin Pharmaceutical Co., Ltd. Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Eishin Pharmaceutical Co., Ltd. Probiotic Pills Product Portfolio Table 94. Eishin Pharmaceutical Co., Ltd. Recent Development Table 95. DSM Company Information Table 96. DSM Business Overview Table 97. DSM Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. DSM Probiotic Pills Product Portfolio Table 99. DSM Recent Development Table 100. CVS Caremark Company Information Table 101. CVS Caremark Business Overview Table 102. CVS Caremark Probiotic Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. CVS Caremark Probiotic Pills Product Portfolio Table 104. CVS Caremark Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Probiotic Pills Distributors List Table 108. Probiotic Pills Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Probiotic Pills Product Image Figure 2. Global Probiotic Pills Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotic Pills Sales Value (2021-2032) & (US$ Million) Figure 4. Global Probiotic Pills Sales (2021-2032) & (K Units) Figure 5. Global Probiotic Pills Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Probiotic Pills Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsule Image Figure 10. Medicinal Tablet Image Figure 11. Other Image Figure 12. Global Probiotic Pills Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Probiotic Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Probiotic Pills Sales Volume Share by Type (2021-2032) Figure 15. Global Probiotic Pills Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Probiotic Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Probiotic Pills Sales Value Share by Type (2021-2032) Figure 18. E-commerce Image Figure 19. Drugstore Image Figure 20. Clinic Image Figure 21. Global Probiotic Pills Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Probiotic Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Probiotic Pills Sales Volume Share by Application (2021-2032) Figure 24. Global Probiotic Pills Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Probiotic Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Probiotic Pills Sales Value Share by Application (2021-2032) Figure 27. Global Probiotic Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Probiotic Pills Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Probiotic Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Probiotic Pills Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Probiotic Pills Sales Value (2021-2032) & (US$ Million) Figure 32. North America Probiotic Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Probiotic Pills Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Probiotic Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Probiotic Pills Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Probiotic Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Probiotic Pills Sales Value (2021-2032) & (US$ Million) Figure 38. South America Probiotic Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Probiotic Pills Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Probiotic Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Probiotic Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Probiotic Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Probiotic Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Probiotic Pills Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Probiotic Pills Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Medicinal Tablet
  • Other
Applications
  • E-commerce
  • Drugstore
  • Clinic
Companies covered
  • Votary
  • Smidge
  • OHKISEIYAKU
  • Nutrition Care Pharmaceuticals
  • L.P Gentle Herbal
  • Eishin Pharmaceutical Co., Ltd.
  • DSM
  • CVS Caremark

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Probiotic Pills Sales Value (2021-2032)
  4. 1.2.2 Global Probiotic Pills Sales Volume (2021-2032)
  5. 1.2.3 Global Probiotic Pills Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Probiotic Pills Market Dynamics
  1. 2.1 Probiotic Pills Industry Trends
  2. 2.2 Probiotic Pills Industry Drivers
  3. 2.3 Probiotic Pills Industry Opportunities and Challenges
  4. 2.4 Probiotic Pills Industry Restraints
3 Probiotic Pills Market by Company
  1. 3.1 Global Probiotic Pills Company Revenue Ranking in 2025
  2. 3.2 Global Probiotic Pills Revenue by Company (2021-2026)
  3. 3.3 Global Probiotic Pills Sales Volume by Company (2021-2026)
  4. 3.4 Global Probiotic Pills Average Price by Company (2021-2026)
  5. 3.5 Global Probiotic Pills Company Ranking (2024-2026)
  6. 3.6 Global Probiotic Pills Company Manufacturing Base and Headquarters
  7. 3.7 Global Probiotic Pills Company Product Type and Application
  8. 3.8 Global Probiotic Pills Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Probiotic Pills Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Probiotic Pills Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Probiotic Pills Market by Type
  1. 4.1 Probiotic Pills Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Medicinal Tablet
  4. 4.1.3 Other
  5. 4.2 Global Probiotic Pills Sales Volume by Type
  6. 4.2.1 Global Probiotic Pills Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Probiotic Pills Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Probiotic Pills Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Probiotic Pills Sales Value by Type
  10. 4.3.1 Global Probiotic Pills Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Probiotic Pills Sales Value by Type (2021-2032)
  12. 4.3.3 Global Probiotic Pills Sales Value Share by Type (2021-2032)
5 Probiotic Pills Market by Application
  1. 5.1 Probiotic Pills Application Introduction
  2. 5.1.1 E-commerce
  3. 5.1.2 Drugstore
  4. 5.1.3 Clinic
  5. 5.2 Global Probiotic Pills Sales Volume by Application
  6. 5.2.1 Global Probiotic Pills Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Probiotic Pills Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Probiotic Pills Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Probiotic Pills Sales Value by Application
  10. 5.3.1 Global Probiotic Pills Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Probiotic Pills Sales Value by Application (2021-2032)
  12. 5.3.3 Global Probiotic Pills Sales Value Share by Application (2021-2032)
6 Probiotic Pills Regional Sales and Value Analysis
  1. 6.1 Global Probiotic Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Probiotic Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Probiotic Pills Sales by Region: 2021-2026
  4. 6.2.2 Global Probiotic Pills Sales by Region (2027-2032)
  5. 6.3 Global Probiotic Pills Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Probiotic Pills Sales Value by Region (2021-2032)
  7. 6.4.1 Global Probiotic Pills Sales Value by Region: 2021-2026
  8. 6.4.2 Global Probiotic Pills Sales Value by Region (2027-2032)
  9. 6.5 Global Probiotic Pills Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Probiotic Pills Sales Value (2021-2032)
  12. 6.6.2 North America Probiotic Pills Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Probiotic Pills Sales Value (2021-2032)
  15. 6.7.2 Europe Probiotic Pills Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Probiotic Pills Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Probiotic Pills Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Probiotic Pills Sales Value (2021-2032)
  21. 6.9.2 South America Probiotic Pills Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Probiotic Pills Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Probiotic Pills Sales Value Share by Country, 2025 VS 2032
7 Probiotic Pills Country-level Sales and Value Analysis
  1. 7.1 Global Probiotic Pills Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Probiotic Pills Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Probiotic Pills Sales by Country (2021-2032)
  4. 7.3.1 Global Probiotic Pills Sales by Country (2021-2026)
  5. 7.3.2 Global Probiotic Pills Sales by Country (2027-2032)
  6. 7.4 Global Probiotic Pills Sales Value by Country (2021-2032)
  7. 7.4.1 Global Probiotic Pills Sales Value by Country (2021-2026)
  8. 7.4.2 Global Probiotic Pills Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Probiotic Pills Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Probiotic Pills Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Probiotic Pills Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Probiotic Pills Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Probiotic Pills Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Probiotic Pills Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Probiotic Pills Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Probiotic Pills Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Probiotic Pills Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Probiotic Pills Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Probiotic Pills Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Probiotic Pills Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Probiotic Pills Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Probiotic Pills Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Probiotic Pills Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Probiotic Pills Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Probiotic Pills Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Probiotic Pills Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Probiotic Pills Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Probiotic Pills Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Probiotic Pills Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Probiotic Pills Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Probiotic Pills Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Probiotic Pills Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Probiotic Pills Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Probiotic Pills Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Probiotic Pills Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Probiotic Pills Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Probiotic Pills Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Probiotic Pills Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Probiotic Pills Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Votary
  2. 8.1.1 Votary Company Information
  3. 8.1.2 Votary Business Overview
  4. 8.1.3 Votary Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Votary Probiotic Pills Product Portfolio
  6. 8.1.5 Votary Recent Developments
  7. 8.2 Smidge
  8. 8.2.1 Smidge Company Information
  9. 8.2.2 Smidge Business Overview
  10. 8.2.3 Smidge Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Smidge Probiotic Pills Product Portfolio
  12. 8.2.5 Smidge Recent Developments
  13. 8.3 OHKISEIYAKU
  14. 8.3.1 OHKISEIYAKU Company Information
  15. 8.3.2 OHKISEIYAKU Business Overview
  16. 8.3.3 OHKISEIYAKU Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 OHKISEIYAKU Probiotic Pills Product Portfolio
  18. 8.3.5 OHKISEIYAKU Recent Developments
  19. 8.4 Nutrition Care Pharmaceuticals
  20. 8.4.1 Nutrition Care Pharmaceuticals Company Information
  21. 8.4.2 Nutrition Care Pharmaceuticals Business Overview
  22. 8.4.3 Nutrition Care Pharmaceuticals Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nutrition Care Pharmaceuticals Probiotic Pills Product Portfolio
  24. 8.4.5 Nutrition Care Pharmaceuticals Recent Developments
  25. 8.5 L.P Gentle Herbal
  26. 8.5.1 L.P Gentle Herbal Company Information
  27. 8.5.2 L.P Gentle Herbal Business Overview
  28. 8.5.3 L.P Gentle Herbal Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 L.P Gentle Herbal Probiotic Pills Product Portfolio
  30. 8.5.5 L.P Gentle Herbal Recent Developments
  31. 8.6 Eishin Pharmaceutical Co., Ltd.
  32. 8.6.1 Eishin Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Eishin Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Eishin Pharmaceutical Co., Ltd. Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eishin Pharmaceutical Co., Ltd. Probiotic Pills Product Portfolio
  36. 8.6.5 Eishin Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 DSM
  38. 8.7.1 DSM Company Information
  39. 8.7.2 DSM Business Overview
  40. 8.7.3 DSM Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DSM Probiotic Pills Product Portfolio
  42. 8.7.5 DSM Recent Developments
  43. 8.8 CVS Caremark
  44. 8.8.1 CVS Caremark Company Information
  45. 8.8.2 CVS Caremark Business Overview
  46. 8.8.3 CVS Caremark Probiotic Pills Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CVS Caremark Probiotic Pills Product Portfolio
  48. 8.8.5 CVS Caremark Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Probiotic Pills Value Chain Analysis
  2. 9.1.1 Probiotic Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Probiotic Pills Sales Mode & Process
  6. 9.2 Probiotic Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Probiotic Pills Distributors
  9. 9.2.3 Probiotic Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research